COMPARATIVE EFFICACY OF 3 SGLT2 INHIBITORS AS THE FIFTH DRUG IN THE MANAGEMENT OF TYPE 2 DM IN ASIAN INDIANS NOT CONTROLLED WITH ATLEAST 4 ORAL ANTI DIABETIC DRUGS

COMPARATIVE EFFICACY OF 3 SGLT2 INHIBITORS AS THE FIFTH DRUG IN THE MANAGEMENT OF TYPE 2 DM IN ASIAN INDIANS NOT CONTROLLED WITH ATLEAST 4 ORAL ANTI DIABETIC DRUGS

Abstract #1137 Objective: To evaluate comparative efficacy of the 3 SGLT2 inhibitors (Dapagliflozin, Empagliflozin and Canagliflozin) as an add-on therapy along with stricter lifestyle modification in Asian Indian type 2 diabetes mellitus (T2DM) patients with inadequate glycemic control despite rece...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine practice 2017-04, Vol.23, p.309
Hauptverfasser: Vadgama, Jimitkumar, Panikar, Vijay, Joshi, Shashank, Kamat, Tejas, Nasikkar, Nikhil, Sheikh, Saalim, Wagle, Tejal, Jain, Chandni
Format: Artikel
Sprache:eng
Schlagworte:
Antidiabetics
Diabetes
Drugs
Lifestyles
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract #1137 Objective: To evaluate comparative efficacy of the 3 SGLT2 inhibitors (Dapagliflozin, Empagliflozin and Canagliflozin) as an add-on therapy along with stricter lifestyle modification in Asian Indian type 2 diabetes mellitus (T2DM) patients with inadequate glycemic control despite receiving an optimum dose of at least 4 oral antidiabetic drugs...
ISSN:1530-891X
1934-2403